Chinese Biotech Sector Regains Mojo As Listings, Funding Deals Inject $357m
Executive Summary
One initial public offering and six private funding deals add a total of $357m into the biotech funding pot in China as multiple new ventures look to progress pipeline assets and build capabilities.